Taylor D G, Haubenwallner S, Leff T
Department of Biotechnology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
Nucleic Acids Res. 1996 Aug 1;24(15):2930-5. doi: 10.1093/nar/24.15.2930.
The HNF-4 orphan receptor is a member of the nuclear receptor family of transcription factors and a major regulator of genes involved in carbohydrate and lipid metabolism. As an initial step in characterizing the role of HNF-4 in the regulation of metabolism, we have generated a dominant negative form of HNF-4 (DN-HNF-4) that contains a defective DNA-binding domain. In gel mobility shift assays, DN-HNF-4 did not bind an oligonucleotide probe representing an essential HNF-4 binding site, C3P contained in the human apo CIII promoter, but did prevent the binding of two recombinant isoforms, HNF-4alpha1 and HNF-4alpha2, as well as naturally-occurring HNF-4. DN-HNF-4 had no effect on the binding of PPARgamma-RXRalpha heterodimers to a PPAR response element. In transfected HepG2 cells, DN-HNF-4 dramatically reduced constitutive transcriptional activity of the human apo CIII promoter and abolished the positive transcriptional activity caused by plasmids expressing either isoform of HNF-4. These results indicate that DN-HNF-4 is a selective dominant negative mutant which forms defective heterodimers with wild-type HNF-4, thereby preventing DNA binding and subsequent transcriptional activation by HNF-4.
肝细胞核因子4(HNF-4)孤儿受体是转录因子核受体家族的成员,也是参与碳水化合物和脂质代谢的基因的主要调节因子。作为表征HNF-4在代谢调节中作用的第一步,我们构建了一种含有缺陷DNA结合结构域的显性负性形式的HNF-4(DN-HNF-4)。在凝胶迁移率变动分析中,DN-HNF-4不与代表人类载脂蛋白CIII启动子中必需的HNF-4结合位点C3P的寡核苷酸探针结合,但确实阻止了两种重组异构体HNF-4α1和HNF-4α2以及天然存在的HNF-4的结合。DN-HNF-4对PPARγ-RXRα异二聚体与PPAR反应元件的结合没有影响。在转染的HepG2细胞中,DN-HNF-4显著降低了人类载脂蛋白CIII启动子的组成型转录活性,并消除了由表达HNF-4任一异构体的质粒引起的正向转录活性。这些结果表明,DN-HNF-4是一种选择性显性负性突变体,它与野生型HNF-4形成有缺陷的异二聚体,从而阻止HNF-4与DNA结合及随后的转录激活。